EquityZen Growth Technology Fund LLC - Series 175 — Form D/A
EquityZen Growth Technology Fund LLC - Series 175 of New York, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2018-01-31. The offering totals $220K, of which $220K was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2018-01-31
- Form: D/A
- Accession: 0001720460-18-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C.1
- Total offering: $220K
- Amount sold: $220K
- Minimum investment: $10K
- Investors: 17
- Date of first sale: 2018-01-10
- Security types: equity, fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-303542
Issuer
- Name: EquityZen Growth Technology Fund LLC - Series 175
- CIK: 0001720460
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 10 West 18th St, New York, NY, 10011-4618
- Phone: (877) 490-6121
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| LLC Assure Fund Management II | Director | Salt Lake City, UT |
| Shriram Bhashyam | Director | New York, NY |
| LLC EquityZen Advisors | Director | New York, NY |
| Shriram Bhashyam | Executive Officer | New York, NY |
| LLC EquityZen Advisors | Executive Officer | New York, NY |
| Erin Rosenthal | Executive Officer | San Francisco, CA |
Other filings by this issuer (1)
More